Search for: "North American Commercial Co. v. United States"
Results 121 - 140
of 191
Sorted by Relevance
|
Sort by Date
11 Oct 2023, 9:25 am
We now move on to the FAR Cost Principles, specifically FAR Subpart 31.2, which applies to contracts with commercial organizations. [read post]
24 Sep 2021, 7:50 am
Acuity Insurance Co. [read post]
25 Jun 2023, 10:54 am
Claiborne Hardware Co. [read post]
1 Jul 2011, 7:01 am
Research indicates that the decision in Shamil Bank v. [read post]
1 Jul 2011, 7:01 am
Research indicates that the decision in Shamil Bank v. [read post]
16 Jan 2024, 11:33 am
DeJoy and Students for Fair Admissions, Inc. v. [read post]
28 Jun 2018, 4:00 am
Since the precipitous drop in United States law school enrolments began close to a decade ago, enrolments system wide have been cut in half. [read post]
30 May 2008, 9:09 am
: (IP ThinkTank), (further discussion from IAM and e^(ip)) Illusory world of trade secret protection – Discussion of S Schreter’s article ‘Inside entrepreneurship: Patent protection isn’t only option’: (IPBiz) Global – Copyright Illegal art: (Patry Copyright Blog), Events 1-3 June: ACC Europe 2008 annual conference ‘Becoming a global legal manager: Developing the skills you will need to manage the… [read post]
9 Sep 2021, 6:40 pm
Assuming the Administration follows appropriate procedures to adopt the rules, most legal commentators do not expect the legal challenges opposing the mandate orders to be successful in the courts particularly after the Supreme Court refused to overturn or hear arguments for overturning a unanimous decision of a three-judge panel of the United States Court of Appeals for the Seventh Circuit in Klassen v. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
8 May 2012, 5:15 pm
Co., 435 F.3d 252 (3d Cir. 2006). [read post]
14 Feb 2018, 2:57 pm
CalPERS appealed, asserting that its individual suit was timely because the three-year time limit was subject to equitable tolling pursuant to American Pipe & Construction Co. v. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
4 Nov 2023, 9:09 pm
As of July 18, 2023, a total of 10 outbreak-associated cases of hepatitis A have been reported from four states (CA (2), HI (1), OR (1), WA (6)). [read post]
30 Apr 2012, 11:19 am
Recent developments in Texas, United States, and international energy law. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
11 Aug 2023, 10:11 am
IDR Process Suspended The IDR process currently is suspended following the August 3 , 2023 ruling by the United States District Court for the Eastern District of Texas in Texas Medical Association v. [read post]
20 Jun 2023, 7:09 pm
Part V concludes with a report card on how the regime is doing on its thirtieth anniversary. [read post]
2 Aug 2010, 11:15 am
Grace & Co. [read post]
28 Mar 2008, 6:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Forbes interview with M Meurer (co author of ‘Patent Failure’): (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (IAM), (Technological Innovation and Intellectual Property), (Patent Prospector),Rambus – Rambus stock soars following jury’s dismissal of antitrust and fraud charges from Hynix, Micron, and Nanya… [read post]
